|
Recent Newsletters
Cordis inks $1.1B acquisition | PE firm reportedly close to buying 2 Medtronic businesses | FDA clears AI model |
Death after TAVR | Excessive cannabis use linked to greater risk of heart attack, other cardiovascular events |
Surgeons make history | Cardiology groups push for change | Empagliflozin for CKD | More from the last week |
Heart Rhythm: Beloved electrophysiologist killed in accident | FDA's recall update | EP studies during TAVR |
Key takeaways from a new study on CVD, CKD & type 2 diabetes | FDA reviewing Merck's new PAH drug |
World Heart Day webinar to focus on CCTA, FFR-CT | AFib recurrence after ablation | PET in long-COVID patients |
Cardiac Imaging Highlights: CT on the rise | Trading kickbacks for referrals | Nuclear cardiology needs to evolve |